A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Prior Trastuzumab and Pertuzumab.

ABSTRACT:

SUBMITTER: Fischer S 

PROVIDER: S-EPMC9666114 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature